Events - Spark Newswire

4 minute read

Today, 10:31 AM

What you need to know: New all-in-one event management platform delivers fully customizable virtual experiences to transform virtual events into a Community Hub. NEW YORK, Oct. 19, 2022 (GLOBE

2 minute read

Enanta Pharmaceuticals Presents New Preclinical Data For EDP-235, Its Oral, Direct-Acting Antiviral Protease Inhibitor Specifically Designed For The Treatment Of COVID-19 At IDWeek 2022 On October 21

By Benzinga Newsdesk

Today, 10:31 AM

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced new preclinical data supporting

ENTA

2 minute read

Recession Is Imminent, This Wells Fargo Exec Says: How To Navigate The Bear Market Rally

By Robert Kuczmarski

Today, 10:31 AM

Chris Harvey, head of equity strategy for Wells Fargo & Co.

WFC

3 minute read

Caribou Biosciences Presents Case Report On Long-Term Follow Up Of First Patient Dosed In Phase 1 ANTLER Trial At The Lymphoma, Leukemia, & Myeloma Congress 2022 October 18-22

By Benzinga Newsdesk

Today, 10:31 AM

Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the presentation of a case report for long-term follow up on the first patient

CRBU

2 minute read

Design Therapeutics To Present Preclinical Data Highlighting The Potential Of Its GeneTAC Small Molecule, DT-216, For The Treatment Of Friedreich Ataxia At International Congress for Ataxia Research 2022 November 3

By Benzinga Newsdesk

Today, 10:31 AM

Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that preclinical data for the company's novel

DSGN

2 minute read

Tesla Shares Have A Supporter in Congress: House Rep. McKinley Also Likes These 2 Dividend Stocks

By Robert Kuczmarski

Today, 10:31 AM

Republican Congressman David McKinley recently purchased $1,000 to $15,000 shares in Tesla (NASDAQ: TSLA) for a price of $300.80 per share, in an undisclosed position, per Capito

ABT

2 minute read

Merger Monday Vindicated This Analyst Who Nailed BP’s Offer Price As Energy M&A Heats Up

By Robert Kuczmarski

Today, 10:31 AM

On Oct. 4, Wells Fargo & Co. (NYSE: WFC) analyst Michael Blum initiated coverage of Archaea Energy Inc.

4 minute read

BridgeBio Pharma Highlights Its RAS Precision Oncology Portfolio And Shares Compelling Data From Next-Generation G12C Inhibitor And Novel PI3Kα:RAS Breaker Mechanism At The Fourth RAS Initiative Symposium

By Benzinga Newsdesk

Today, 10:31 AM

- BridgeBio to host investor call today (October 17, 2022) at 1:30 pm ET to discuss its two most advanced RAS precision oncology programs – KRASG12C GTP/GDP dual inhibitor development candidate

BBIO

1 minute read

Anavex Life Sciences Announces Late-Breaking Presentation Of Phase 2b/3 Data of Oral ANAVEX 2-73 (blarcamesine) For Early Alzheimer’s Disease At Upcoming Clinical Trials On Alzheimer’s Disease (CTAD) Congress 2022

By Bill Haddad

Today, 10:31 AM

Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and

AVXL

2 minute read

Goldman Analysts Forecast 140% Upside On Sustainable Tech Play Generac

By Robert Kuczmarski

Today, 10:31 AM

Generac Holdings Inc. (NYSE: GNRC) designs and manufactures standby generators, portable generators, lighting, outdoor power equipment and a suite of clean energy products.

GNRC